Australian team's advantage in the COVID-19 vaccine race

According to The Australian Financial Review, Australian researchers, who became the fastest vaccine developers in the world in 2009 by putting the first swine flu vaccine into humans in three months, are now working on one for COVID-19.
They have animal trials under way and expect the results in July. If successful, they will begin testing their candidate vaccine in humans.
If it proves safe and generates the right type of immune response, they say many people, particularly frontline medical staff, could conceivably be given the vaccine under trial conditions.
The team believes it has an advantage because it has an established platform that has proved safe and effective with other vaccines it has produced for outbreaks such as H5 and H7 bird flu.
“We started working on this pandemic platform in 2002," says Professor Nikolai Petrovsky, who has been researching vaccines for 20 years and leads the COVID-19 team from the Flinders University precinct.
​
https://www.afr.com/policy/health-and-education/australian-team-s-advantage-in-the-covid-19-vaccine-race-20200403-p54gv2

If you want to read this article in Japanese, please see the following link:
https://www.j-abc.com/jp-blog/5548352.html
​